Cidara Therapeutics Strikes $128 Million Deal to Divest rezafungin, Bolstering Focus on Cloudbreak Development

  Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical de...

April 25, 2024 | Thursday | News
Exergen Corporation Takes Legal Action to Protect Rights in Face of Baxter International's Censorship Attempt

Exergen Corporation, a leader in temperature measurement technology, has filed a lawsuit against Baxter International Inc. in the United States District Co...

April 24, 2024 | Wednesday | News
Sanofi's Breakthrough BTK Inhibitor Shows Promise for Patients with Persistent and Chronic ITP, Regulatory Submissions Expected Soon

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombo...

April 23, 2024 | Tuesday | News
Ipsen Strikes Option Agreement with Skyhawk for Exclusive Global Rights to Novel Neurological Disease Candidates

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development candida...

April 22, 2024 | Monday | News
SK pharmteco Partners with Ferring Pharmaceuticals to Scale Up Production of ADSTILADRIN® Gene Therapy

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...

April 18, 2024 | Thursday | News
GE HealthCare Launches Voluson Signature 20 and 18 Ultrasound Systems Revolutionizing Women's Health Diagnosis

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), adv...

April 18, 2024 | Thursday | News
INTERPHEX24: Industry Leaders Redefine Decontamination Protocols for Sterile Product Manufacturing

  The quest for efficiency without compromising safety and compliance is paramount. This was the central theme of the panel discussion titled "Reimag...

April 17, 2024 | Wednesday | Expert Opinion
Industry Titans Illuminate Path to Pharmaceutical Innovation at INTERPHEX 2024

Industry pioneers Maria Batalha, Kevin J. Bittorf, Matthew Mollan, and John Nadzam took center stage at INTERPHEX 2024 to share their expertise and insight...

April 17, 2024 | Wednesday | Expert Opinion
Agilent Technologies' GenetiSure Dx Postnatal Assay Earns European IVDR Class C Certification

Agilent Technologies Inc.  announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demon...

April 15, 2024 | Monday | News
EFA Technologies Launches Operations in Brazil with Revolutionary Portable Blood Lab

This expansion comes in the wake of regulatory approval granted last October by Anvisa, the Brazilian health regulatory authority, for EFA's groundbreaking...

April 10, 2024 | Wednesday | News
Hartwig Medical Foundation and Ultima Genomics Partner to Enhance Cancer Genomic Profiling

-Hartwig Medical Foundation, a pioneer in deploying complete genomic profiling to improve oncology outcomes, and Ultima Genomics, a developer of a revoluti...

April 08, 2024 | Monday | News
Nucleai and GoPath Diagnostics Partner to Advance Digital Pathology with AI Integration

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...

April 08, 2024 | Monday | News
Bruker Introduces Novel NMR Capabilities for Structural Biology in Proteins

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel hig...

April 08, 2024 | Monday | News
GE HealthCare Introduces Caption AI for Vscan Air SL Ultrasound System, Enhancing Cardiac Care Accessibility

GE HealthCare (Nasdaq: GEHC) announces a groundbreaking advancement in cardiac care with the launch of Caption AI artificial intelligence (AI)-driven softw...

April 04, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close